Curcumin against Prostate Cancer: Current Evidence.
Deborah TerminiDanja J Den HartoghAlina JaglanianEvangelia TsianiPublished in: Biomolecules (2020)
Cancer is a condition characterized by remarkably enhanced rates of cell proliferation paired with evasion of cell death. These deregulated cellular processes take place following genetic mutations leading to the activation of oncogenes, the loss of tumor suppressor genes, and the disruption of key signaling pathways that control and promote homeostasis. Plant extracts and plant-derived compounds have historically been utilized as medicinal remedies in different cultures due to their anti-inflammatory, antioxidant, and antimicrobial properties. Many chemotherapeutic agents used in the treatment of cancer are derived from plants, and the scientific interest in discovering plant-derived chemicals with anticancer potential continues today. Curcumin, a turmeric-derived polyphenol, has been reported to possess antiproliferative and proapoptotic properties. In the present review, we summarize all the in vitro and in vivo studies examining the effects of curcumin in prostate cancer.
Keyphrases
- prostate cancer
- papillary thyroid
- anti inflammatory
- cell death
- cell proliferation
- radical prostatectomy
- squamous cell
- signaling pathway
- genome wide
- staphylococcus aureus
- oxidative stress
- cell wall
- cell cycle
- childhood cancer
- gene expression
- epithelial mesenchymal transition
- transcription factor
- genome wide identification
- genome wide analysis